For the first time, the authors demonstrated the detectability of BCR-ABL1 transcripts in exosomes isolated from CML patients who were under treatment and presenting undetectable MRD levels [108,129]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.